Hypertension: treating elderly patients reduces cardiovascular events
|
|
|
Clinical bottom line (level 1a)
-
Elderly patients with hypertension who take antihypertensive medication are less likely to have cardiovascular events
(NNT =
18
at 5
years)
.
|
|
Mulrow et al:
Journal of the American Medical Association
1994;
272 (24):
1932-1938
|
Expires
February 2003
|
The study
Systematic review of all randomised controlled trials
of
Patients: aged > 65 with hypertension
Intervention: antihypertensive medication
Outcome: cardiovascular event
Articles found in English
using Medline, 1966 to 1993
(search terms: hypertension, elderly or aged or geriatric and morbidity or mortality or randomized controlled trials
)
and searching reference lists of retrieved articles
Selection criteria: by 2 independent reviewers: detailed in text
Appraisal criteria: blinding, drop-out rates, intention-to-treat
Articles excluded if: - study lasted < 1 year
- patients aged < 60
13 studies found - 6 were high quality.
No significant heterogeneity was noted.
The evidence
| Outcome |
Time to outcome |
CER |
OR (95% CI) |
NNT (95% CI) |
| cardiovascular event
|
5
years |
/
(%) |
( to
)
|
18
(14 to
25)
|
| cerebrovascular event
|
5
years |
/
(%) |
( to
)
|
43
(31 to
69)
|
| coronary heart disease event
|
5
years |
/
(%) |
( to
)
|
61
(39 to
141)
|
- The majority of patients were taking either beta-blockers or diuretics.
- No odds ratios were reported, only numbers-needed-to-treat.
Comments
- There are only studies in elderly <85 years of age, and at the moment it is not certain that we can extrapolate the results to the very elderly.
- Two to four times more young patients need to be treated compared with elderly patients to prevent one cardiovascular event.
- The hypertensive elderly at large differ in several respects and the application of trial results from relatively healthy elderly to, for example, frail elderly may be difficult.
Citation
-
Mulrow
CD,
Cornell
JA,
Herrera
CR, et al:
hypertension in the elderly; implications and generalizability of randomized trials.
Journal of the American Medical Association
1994;
272 (24):
1932-1938
Contributor: Chris Ball and Clare Wotton,
February 2000
Reviewer: Timo Strandberg
Clinical Question.
| Patient |
elderly with hypertension |
| Intervention or Exposure |
antihypertensive medication |
| Outcome |
cardiovascular events |
|
|